News
12 Health Care Stocks Moving In Friday's Intraday Session
5 Apr 24
Movers
Dow Dips Over 200 Points; RPM International Shares Fall After Q3 Results
4 Apr 24
Earnings, News, Penny Stocks, Eurozone, Commodities, Global, Intraday Update, Markets, Trading Ideas
Why STAAR Surgical Shares Are Trading Higher By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
4 Apr 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
12 Health Care Stocks Moving In Thursday's Intraday Session
4 Apr 24
Movers
Nasdaq Surges 1%; ConAgra Brands Posts Upbeat Earnings
4 Apr 24
Earnings, News, Penny Stocks, Eurozone, Commodities, Global, Intraday Update, Markets, Trading Ideas
Cancer-Focused eFFECTOR Therapeutics Shelves Development Of Lung Cancer Candidate After Disappointing Data
4 Apr 24
Biotech, News, Health Care, Movers, General
Dow Jumps Over 100 Points; US Jobless Claims Increase To 221,000
4 Apr 24
Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets, Trading Ideas
eFFECTOR Therapeutics Announces Topline Results Of Phase 2 KICKSTART Trial Of Tomivosertib Combined With Pembrolizumab In Non-Small Cell Lung Cancer
4 Apr 24
Biotech, News, General
HC Wainwright & Co. Reiterates Buy on eFFECTOR Therapeutics, Maintains $24 Price Target
28 Mar 24
News, Price Target, Reiteration, Analyst Ratings
eFFECTOR Therapeutics Cash, Cash Equivalents, And Short-Term Investments Totaling $18.4M As Of December 31, 2023; Anticipates That It Will Be Sufficient To Fund Operations Into Q1 Of 2025
25 Mar 24
News, Guidance
eFFECTOR Therapeutics Q4 EPS $(3.42) Misses $(1.65) Estimate
25 Mar 24
Earnings, News
12 Health Care Stocks Moving In Friday's Intraday Session
8 Mar 24
Movers
HC Wainwright & Co. Maintains Buy on eFFECTOR Therapeutics, Adjusts Price Target To $24
6 Feb 24
News, Price Target, Analyst Ratings
eFFECTOR Therapeutics Announces $15M Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
25 Jan 24
News, Offerings
12 Health Care Stocks Moving In Wednesday's After-Market Session
24 Jan 24
Movers
Press releases
eFFECTOR Therapeutics Announces Topline Results of Phase 2 KICKSTART Trial of Tomivosertib Combined with Pembrolizumab in Non-Small Cell Lung Cancer
4 Apr 24
Health Care, Press Releases
eFFECTOR Therapeutics to Present at Oppenheimer 34th Annual Healthcare Life Sciences Conference
5 Feb 24
News, Press Releases
eFFECTOR Therapeutics Announces Closing of $15 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
29 Jan 24
Press Releases
Thinking about buying stock in LAVA Therapeutics, UP Fintech Holding, Babcock & Wilcox Enterprises, Safety Shot, or eFFECTOR Therapeutics?
25 Jan 24
Opinion, Press Releases